3-AZIDO-NUCLEOSIDES

The present invention relates to certain novel 3 min -azidonucleosides and pharmaceutically acceptable derivatives thereof; the use of certain 3 min -azidonucleosides, their pharmaceutically acceptable derivatives and therapeutic combinations containing them, in therapy, particularly in the treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PHILLIP ALLEN FURMAN, SAMMY RAY SHAVER, LEONE EDWARD KIRK III, GERALD WOLBERG, THOMAS PAUL ZIMMERMAN, DANNIE HILLEARY KING, MARTHA HEIDER ST. CLAIR, GEOFFREY WHITE, GEORGE ANDREW FREEMAN, PAULO M. DE MIRANDA, DAVID WALTER BARRY, JANET LITSTER RIDEOUT, SANDRA NUSINOFF LEHRMAN, RICHARD HARLON CLEMONS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PHILLIP ALLEN FURMAN
SAMMY RAY SHAVER
LEONE EDWARD KIRK III
GERALD WOLBERG
THOMAS PAUL ZIMMERMAN
DANNIE HILLEARY KING
MARTHA HEIDER ST. CLAIR
GEOFFREY WHITE
GEORGE ANDREW FREEMAN
PAULO M. DE MIRANDA
DAVID WALTER BARRY
JANET LITSTER RIDEOUT
SANDRA NUSINOFF LEHRMAN
RICHARD HARLON CLEMONS
description The present invention relates to certain novel 3 min -azidonucleosides and pharmaceutically acceptable derivatives thereof; the use of certain 3 min -azidonucleosides, their pharmaceutically acceptable derivatives and therapeutic combinations containing them, in therapy, particularly in the treatment and prophylaxis of gram negative bacterial infections and retroviral infections, especially AIDS; to processes for the preparation of 3 min -azidonucleosides; and to formulations containing them.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU6270286A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU6270286A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU6270286A3</originalsourceid><addsrcrecordid>eNrjZBA21nWM8nTx1_ULdfZx9Q_2dHEN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hZkbmBkYWZo7GhFUAAODBHYA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-AZIDO-NUCLEOSIDES</title><source>esp@cenet</source><creator>PHILLIP ALLEN FURMAN ; SAMMY RAY SHAVER ; LEONE EDWARD KIRK III ; GERALD WOLBERG ; THOMAS PAUL ZIMMERMAN ; DANNIE HILLEARY KING ; MARTHA HEIDER ST. CLAIR ; GEOFFREY WHITE ; GEORGE ANDREW FREEMAN ; PAULO M. DE MIRANDA ; DAVID WALTER BARRY ; JANET LITSTER RIDEOUT ; SANDRA NUSINOFF LEHRMAN ; RICHARD HARLON CLEMONS</creator><creatorcontrib>PHILLIP ALLEN FURMAN ; SAMMY RAY SHAVER ; LEONE EDWARD KIRK III ; GERALD WOLBERG ; THOMAS PAUL ZIMMERMAN ; DANNIE HILLEARY KING ; MARTHA HEIDER ST. CLAIR ; GEOFFREY WHITE ; GEORGE ANDREW FREEMAN ; PAULO M. DE MIRANDA ; DAVID WALTER BARRY ; JANET LITSTER RIDEOUT ; SANDRA NUSINOFF LEHRMAN ; RICHARD HARLON CLEMONS</creatorcontrib><description>The present invention relates to certain novel 3 min -azidonucleosides and pharmaceutically acceptable derivatives thereof; the use of certain 3 min -azidonucleosides, their pharmaceutically acceptable derivatives and therapeutic combinations containing them, in therapy, particularly in the treatment and prophylaxis of gram negative bacterial infections and retroviral infections, especially AIDS; to processes for the preparation of 3 min -azidonucleosides; and to formulations containing them.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; SUGARS</subject><creationdate>1987</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19870319&amp;DB=EPODOC&amp;CC=AU&amp;NR=6270286A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19870319&amp;DB=EPODOC&amp;CC=AU&amp;NR=6270286A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PHILLIP ALLEN FURMAN</creatorcontrib><creatorcontrib>SAMMY RAY SHAVER</creatorcontrib><creatorcontrib>LEONE EDWARD KIRK III</creatorcontrib><creatorcontrib>GERALD WOLBERG</creatorcontrib><creatorcontrib>THOMAS PAUL ZIMMERMAN</creatorcontrib><creatorcontrib>DANNIE HILLEARY KING</creatorcontrib><creatorcontrib>MARTHA HEIDER ST. CLAIR</creatorcontrib><creatorcontrib>GEOFFREY WHITE</creatorcontrib><creatorcontrib>GEORGE ANDREW FREEMAN</creatorcontrib><creatorcontrib>PAULO M. DE MIRANDA</creatorcontrib><creatorcontrib>DAVID WALTER BARRY</creatorcontrib><creatorcontrib>JANET LITSTER RIDEOUT</creatorcontrib><creatorcontrib>SANDRA NUSINOFF LEHRMAN</creatorcontrib><creatorcontrib>RICHARD HARLON CLEMONS</creatorcontrib><title>3-AZIDO-NUCLEOSIDES</title><description>The present invention relates to certain novel 3 min -azidonucleosides and pharmaceutically acceptable derivatives thereof; the use of certain 3 min -azidonucleosides, their pharmaceutically acceptable derivatives and therapeutic combinations containing them, in therapy, particularly in the treatment and prophylaxis of gram negative bacterial infections and retroviral infections, especially AIDS; to processes for the preparation of 3 min -azidonucleosides; and to formulations containing them.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1987</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBA21nWM8nTx1_ULdfZx9Q_2dHEN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hZkbmBkYWZo7GhFUAAODBHYA</recordid><startdate>19870319</startdate><enddate>19870319</enddate><creator>PHILLIP ALLEN FURMAN</creator><creator>SAMMY RAY SHAVER</creator><creator>LEONE EDWARD KIRK III</creator><creator>GERALD WOLBERG</creator><creator>THOMAS PAUL ZIMMERMAN</creator><creator>DANNIE HILLEARY KING</creator><creator>MARTHA HEIDER ST. CLAIR</creator><creator>GEOFFREY WHITE</creator><creator>GEORGE ANDREW FREEMAN</creator><creator>PAULO M. DE MIRANDA</creator><creator>DAVID WALTER BARRY</creator><creator>JANET LITSTER RIDEOUT</creator><creator>SANDRA NUSINOFF LEHRMAN</creator><creator>RICHARD HARLON CLEMONS</creator><scope>EVB</scope></search><sort><creationdate>19870319</creationdate><title>3-AZIDO-NUCLEOSIDES</title><author>PHILLIP ALLEN FURMAN ; SAMMY RAY SHAVER ; LEONE EDWARD KIRK III ; GERALD WOLBERG ; THOMAS PAUL ZIMMERMAN ; DANNIE HILLEARY KING ; MARTHA HEIDER ST. CLAIR ; GEOFFREY WHITE ; GEORGE ANDREW FREEMAN ; PAULO M. DE MIRANDA ; DAVID WALTER BARRY ; JANET LITSTER RIDEOUT ; SANDRA NUSINOFF LEHRMAN ; RICHARD HARLON CLEMONS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU6270286A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1987</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>PHILLIP ALLEN FURMAN</creatorcontrib><creatorcontrib>SAMMY RAY SHAVER</creatorcontrib><creatorcontrib>LEONE EDWARD KIRK III</creatorcontrib><creatorcontrib>GERALD WOLBERG</creatorcontrib><creatorcontrib>THOMAS PAUL ZIMMERMAN</creatorcontrib><creatorcontrib>DANNIE HILLEARY KING</creatorcontrib><creatorcontrib>MARTHA HEIDER ST. CLAIR</creatorcontrib><creatorcontrib>GEOFFREY WHITE</creatorcontrib><creatorcontrib>GEORGE ANDREW FREEMAN</creatorcontrib><creatorcontrib>PAULO M. DE MIRANDA</creatorcontrib><creatorcontrib>DAVID WALTER BARRY</creatorcontrib><creatorcontrib>JANET LITSTER RIDEOUT</creatorcontrib><creatorcontrib>SANDRA NUSINOFF LEHRMAN</creatorcontrib><creatorcontrib>RICHARD HARLON CLEMONS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PHILLIP ALLEN FURMAN</au><au>SAMMY RAY SHAVER</au><au>LEONE EDWARD KIRK III</au><au>GERALD WOLBERG</au><au>THOMAS PAUL ZIMMERMAN</au><au>DANNIE HILLEARY KING</au><au>MARTHA HEIDER ST. CLAIR</au><au>GEOFFREY WHITE</au><au>GEORGE ANDREW FREEMAN</au><au>PAULO M. DE MIRANDA</au><au>DAVID WALTER BARRY</au><au>JANET LITSTER RIDEOUT</au><au>SANDRA NUSINOFF LEHRMAN</au><au>RICHARD HARLON CLEMONS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-AZIDO-NUCLEOSIDES</title><date>1987-03-19</date><risdate>1987</risdate><abstract>The present invention relates to certain novel 3 min -azidonucleosides and pharmaceutically acceptable derivatives thereof; the use of certain 3 min -azidonucleosides, their pharmaceutically acceptable derivatives and therapeutic combinations containing them, in therapy, particularly in the treatment and prophylaxis of gram negative bacterial infections and retroviral infections, especially AIDS; to processes for the preparation of 3 min -azidonucleosides; and to formulations containing them.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU6270286A
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
title 3-AZIDO-NUCLEOSIDES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A14%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PHILLIP%20ALLEN%20FURMAN&rft.date=1987-03-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU6270286A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true